Literature DB >> 17626084

Minute virus of mice, a parvovirus, in complex with the Fab fragment of a neutralizing monoclonal antibody.

Bärbel Kaufmann1, Alberto López-Bueno, Mauricio G Mateu, Paul R Chipman, Christian D S Nelson, Colin R Parrish, José M Almendral, Michael G Rossmann.   

Abstract

The structure of virus-like particles of the lymphotropic, immunosuppressive strain of minute virus of mice (MVMi) in complex with the neutralizing Fab fragment of the mouse monoclonal antibody (MAb) B7 was determined by cryo-electron microscopy to 7-A resolution. The Fab molecule recognizes a conformational epitope at the vertex of a three-fold protrusion on the viral surface, thereby simultaneously engaging three symmetry-related viral proteins in binding. The location of the epitope close to the three-fold axis is consistent with the previous analysis of MVMi mutants able to escape from the B7 antibody. The binding site close to the symmetry axes sterically forbids the binding of more than one Fab molecule per spike. MAb as well as the Fab molecules inhibits the binding of the minute virus of mice (MVM) to permissive cells but can also neutralize MVM postattachment. This finding suggests that the interaction of B7 with three symmetry-related viral subunits at each spike hinders structural transitions in the viral capsid essential during viral entry.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17626084      PMCID: PMC2045413          DOI: 10.1128/JVI.00775-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  77 in total

1.  Low pH-dependent endosomal processing of the incoming parvovirus minute virus of mice virion leads to externalization of the VP1 N-terminal sequence (N-VP1), N-VP2 cleavage, and uncoating of the full-length genome.

Authors:  Bernhard Mani; Claudia Baltzer; Noelia Valle; José M Almendral; Christoph Kempf; Carlos Ros
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

2.  Expression of muscovy duck parvovirus capsid proteins (VP2 and VP3) in a baculovirus expression system and demonstration of immunity induced by the recombinant proteins.

Authors:  G Le Gall-Reculé; V Jestin; P Chagnaud; P Blanchard; A Jestin
Journal:  J Gen Virol       Date:  1996-09       Impact factor: 3.891

3.  The parvovirus MVM: a comparison of heavy and light particle infectivity and their density conversion in vitro.

Authors:  G M Clinton; M Hayashi
Journal:  Virology       Date:  1976-10-01       Impact factor: 3.616

4.  A minute virus of mice.

Authors:  L V Crawford
Journal:  Virology       Date:  1966-08       Impact factor: 3.616

5.  Host range mutants of Minute Virus of Mice with a single VP2 amino acid change require additional silent mutations that regulate NS2 accumulation.

Authors:  Anthony M D'Abramo; A Afshan Ali; Feng Wang; Susan F Cotmore; Peter Tattersall
Journal:  Virology       Date:  2005-09-15       Impact factor: 3.616

6.  Virulent variants emerging in mice infected with the apathogenic prototype strain of the parvovirus minute virus of mice exhibit a capsid with low avidity for a primary receptor.

Authors:  Mari-Paz Rubio; Alberto López-Bueno; José M Almendral
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

7.  Reciprocal productive and restrictive virus-cell interactions of immunosuppressive and prototype strains of minute virus of mice.

Authors:  P Tattersall; J Bratton
Journal:  J Virol       Date:  1983-06       Impact factor: 5.103

8.  Nuclear export of the nonenveloped parvovirus virion is directed by an unordered protein signal exposed on the capsid surface.

Authors:  Beatriz Maroto; Noelia Valle; Rainer Saffrich; José M Almendral
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

9.  Functional implications of the structure of the murine parvovirus, minute virus of mice.

Authors:  M Agbandje-McKenna; A L Llamas-Saiz; F Wang; P Tattersall; M G Rossmann
Journal:  Structure       Date:  1998-11-15       Impact factor: 5.006

10.  B-cell epitopes of canine parvovirus: distribution on the primary structure and exposure on the viral surface.

Authors:  J P Langeveld; J I Casal; C Vela; K Dalsgaard; S H Smale; W C Puijk; R H Meloen
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

View more
  14 in total

1.  Structure of adeno-associated virus-2 in complex with neutralizing monoclonal antibody A20.

Authors:  Dustin M McCraw; Jason K O'Donnell; Kenneth A Taylor; Scott M Stagg; Michael S Chapman
Journal:  Virology       Date:  2012-06-09       Impact factor: 3.616

2.  Capsid antibodies to different adeno-associated virus serotypes bind common regions.

Authors:  Brittney L Gurda; Michael A DiMattia; Edward B Miller; Antonette Bennett; Robert McKenna; Wendy S Weichert; Christian D Nelson; Wei-jun Chen; Nicholas Muzyczka; Norman H Olson; Robert S Sinkovits; John A Chiorini; Sergei Zolotutkhin; Olga G Kozyreva; R Jude Samulski; Timothy S Baker; Colin R Parrish; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2013-06-12       Impact factor: 5.103

3.  Visualization of the externalized VP2 N termini of infectious human parvovirus B19.

Authors:  Bärbel Kaufmann; Paul R Chipman; Victor A Kostyuchenko; Susanne Modrow; Michael G Rossmann
Journal:  J Virol       Date:  2008-05-28       Impact factor: 5.103

4.  Structural characterization of H-1 parvovirus: comparison of infectious virions to empty capsids.

Authors:  Sujata Halder; Hyun-Joo Nam; Lakshmanan Govindasamy; Michèle Vogel; Christiane Dinsart; Nathalie Salomé; Robert McKenna; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2013-02-28       Impact factor: 5.103

5.  Structure of Parvovirus B19 Decorated by Fabs from a Human Antibody.

Authors:  Yingyuan Sun; Thomas Klose; Yue Liu; Susanne Modrow; Michael G Rossmann
Journal:  J Virol       Date:  2019-04-17       Impact factor: 5.103

6.  Adeno-associated virus serotype 1 (AAV1)- and AAV5-antibody complex structures reveal evolutionary commonalities in parvovirus antigenic reactivity.

Authors:  Yu-Shan Tseng; Brittney L Gurda; Paul Chipman; Robert McKenna; Sandra Afione; John A Chiorini; Nicholas Muzyczka; Norman H Olson; Timothy S Baker; Jürgen Kleinschmidt; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2014-11-19       Impact factor: 5.103

7.  Antiangiogenic Vascular Endothelial Growth Factor-Blocking Peptides Displayed on the Capsid of an Infectious Oncolytic Parvovirus: Assembly and Immune Interactions.

Authors:  Esther Grueso; Cristina Sánchez-Martínez; Tania Calvo-López; Fernando J de Miguel; Noelia Blanco-Menéndez; Marian Fernandez-Estevez; Maria Elizalde; Jorge Sanchez; Omar Kourani; Diana Martin; Aroa Tato; Milagros Guerra; Germán Andrés; José M Almendral
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

8.  Viral oncolysis that targets Raf-1 signaling control of nuclear transport.

Authors:  Laura Riolobos; Noelia Valle; Eva Hernando; Beatriz Maroto; Michael Kann; José M Almendral
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

Review 9.  Parvovirus Capsid-Antibody Complex Structures Reveal Conservation of Antigenic Epitopes Across the Family.

Authors:  Shanan N Emmanuel; Mario Mietzsch; Yu Shan Tseng; James Kennon Smith; Mavis Agbandje-McKenna
Journal:  Viral Immunol       Date:  2020-04-21       Impact factor: 2.257

10.  The Mammalian Cell Cycle Regulates Parvovirus Nuclear Capsid Assembly.

Authors:  Jon Gil-Ranedo; Eva Hernando; Laura Riolobos; Carlos Domínguez; Michael Kann; José M Almendral
Journal:  PLoS Pathog       Date:  2015-06-11       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.